U.S., Sept. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07818954) titled 'Subcostal TAP Block and EEG Dynamics in Laparoscopic Cholecystectomy' on Sept. 08. Brief ... Read More
Singapore, Sept. 15 -- The Health Sciences Authority received information related to the study titled 'A Global, Multicentre, Phase II Platform Study of Datopotamab Deruxtecan (Dato-DXd)-based Combina... Read More
Singapore, Sept. 15 -- The Health Sciences Authority received information related to the study titled 'A Phase Ib, Open-Label, Multicenter Study of EBC-129 Combined With Osimertinib in Patients With A... Read More
Singapore, Sept. 15 -- The Health Sciences Authority received information related to the study titled 'ROSETTA Lung-201: A Randomized, Multicenter, Open-label Phase 3 Study of Pumitamig Monotherapy Co... Read More
Singapore, Sept. 15 -- The Health Sciences Authority received information related to the study titled 'A Phase 2, Randomized, Open-Label Study of VVD-133214 in Combination with Pembrolizumab compared ... Read More
U.S., Sept. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07818304) titled 'SRT Combined With Envafolimab and Endostar in the First-line Treatment of Advanced NSCLC' ... Read More
Singapore, Sept. 15 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Investigator Choice of Chemother... Read More
Singapore, Sept. 15 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Investigator Choice of Chemother... Read More
Singapore, Sept. 15 -- The Health Sciences Authority received information related to the study titled 'A longitudinal study to investigate innate immune reprogramming following Herpes Zoster vaccinati... Read More
Singapore, Sept. 15 -- The Health Sciences Authority received information related to the study titled 'Phase I/II study of Mezigdomide and Elranatamab for relapsed/refractory multiple myeloma patients... Read More